HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takanori Hirose Selected Research

RNA-Binding Protein EWS

10/2021Spinal cord astroblastoma with EWSR1-BEND2 fusion classified as HGNET-MN1 by methylation classification: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takanori Hirose Research Topics

Disease

51Neoplasms (Cancer)
01/2024 - 10/2002
9Glioma (Gliomas)
01/2023 - 01/2002
6Sarcoma (Soft Tissue Sarcoma)
01/2022 - 01/2002
4Neoplasm Metastasis (Metastasis)
04/2021 - 08/2003
4Ependymoma
01/2021 - 01/2007
4Astrocytoma (Pilocytic Astrocytoma)
01/2021 - 05/2006
4Glioblastoma (Glioblastoma Multiforme)
11/2020 - 05/2006
3Neurofibroma
01/2023 - 04/2003
3Meningioma (Meningiomas)
01/2022 - 01/2005
3Neuroepithelial Neoplasms (Gliomatosis Cerebri)
10/2021 - 08/2008
3Lymphoma (Lymphomas)
01/2020 - 05/2005
3Carcinoma (Carcinomatosis)
11/2019 - 08/2005
3Hemangioblastoma
04/2015 - 01/2005
3Liposarcoma
08/2011 - 09/2006
2Ewing Sarcoma (Sarcoma, Ewing)
10/2021 - 04/2021
2Oligodendroglioma
10/2013 - 03/2012
2Hyperplasia
04/2008 - 05/2005
2Chordoma
07/2005 - 02/2004
2Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
08/2003 - 04/2003
1Hematologic Neoplasms (Hematological Malignancy)
05/2023
1Osteosclerosis
05/2023
1Angiofibroma
01/2023
1Solitary Fibrous Tumors
01/2023
1Soft Tissue Neoplasms
01/2022
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
04/2021
1Colonic Neoplasms (Colon Cancer)
03/2021
1Synovial Sarcoma (Synovioma)
03/2021
1Clear Cell Sarcoma
12/2020
1Thrombosis (Thrombus)
11/2019
1Hemangiosarcoma (Angiosarcoma)
11/2019
1Tuberous Sclerosis (Bourneville's Disease)
01/2019
1Lymphangioleiomyomatosis (Lymphangiomyomatosis)
01/2019
1Hepatocellular Carcinoma (Hepatoma)
05/2016

Drug/Important Bio-Agent (IBA)

10S100 Proteins (S 100 Protein)IBA
12/2020 - 04/2002
9Proteins (Proteins, Gene)FDA Link
01/2024 - 04/2003
7Keratins (Keratin)IBA
12/2020 - 04/2003
6Glial Fibrillary Acidic ProteinIBA
04/2015 - 04/2002
5Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2023 - 03/2012
5DesminIBA
12/2020 - 08/2003
5SynaptophysinIBA
12/2020 - 04/2002
5VimentinIBA
12/2020 - 08/2003
4Mucin-1 (CA 15-3 Antigen)IBA
04/2015 - 04/2003
3DNA (Deoxyribonucleic Acid)IBA
05/2022 - 03/2012
3CAM 5.2 antigenIBA
01/2021 - 02/2005
3CytokinesIBA
11/2020 - 09/2015
3Interleukin-10 (Interleukin 10)IBA
01/2020 - 09/2015
3Interleukin-6 (Interleukin 6)IBA
10/2019 - 08/2011
3AntibodiesIBA
04/2019 - 01/2005
3CollagenIBA
10/2012 - 08/2003
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
08/2011 - 10/2004
3Cyclin-Dependent Kinase 4IBA
10/2006 - 01/2002
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2020
2GadoliniumIBA
10/2021 - 08/2008
2ChemokinesIBA
11/2020 - 01/2020
2Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
04/2019 - 01/2018
2Carcinoembryonic AntigenIBA
03/2016 - 03/2011
2Neurofilament ProteinsIBA
08/2010 - 04/2002
2Cisplatin (Platino)FDA LinkGeneric
01/2010 - 10/2004
2Prion ProteinsIBA
10/2007 - 10/2002
2ErbB Receptors (EGF Receptor)IBA
02/2007 - 01/2002
2LipidsIBA
07/2005 - 10/2002
2Bromocriptine (Parlodel)FDA LinkGeneric
07/2005 - 04/2005
2Cadherins (E-Cadherin)IBA
01/2005 - 02/2004
2beta CateninIBA
01/2005 - 02/2004
2Cell Adhesion MoleculesIBA
01/2005 - 02/2004
1OsteoprotegerinIBA
05/2023
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2023
1alpha-hydroxyglutarateIBA
01/2023
1Essential Amino AcidsIBA
01/2022
1Phenylalanine (L-Phenylalanine)FDA Link
01/2022
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
01/2022
15'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA
01/2022
1RNA-Binding Protein EWSIBA
10/2021
1Inhibins (Inhibin)IBA
12/2020
1Muramidase (Lysozyme)IBA
11/2020
1VemurafenibIBA
11/2020
14- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamideIBA
11/2020
1Histocompatibility Antigens Class IIIBA
11/2020
1Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2020
1LigandsIBA
01/2020
1succinyl- interleukin-2IBA
01/2020
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2019
1NF-kappa B (NF-kB)IBA
04/2019
1lipoarabinomannan (LAM)IBA
01/2019
1RNA (Ribonucleic Acid)IBA
12/2018
1Monomeric GTP-Binding ProteinsIBA
01/2018
1Collagen Type III (Type III Collagen)IBA
01/2018
1Neurofibromin 1 (Neurofibromin)IBA
01/2018
1SOXB1 Transcription FactorsIBA
01/2018
1tranilastIBA
01/2018
1MART-1 AntigenIBA
01/2017
1multidrug resistance protein 3IBA
05/2016
1Member 11 Subfamily B ATP Binding Cassette TransporterIBA
05/2016

Therapy/Procedure

11Therapeutics
01/2022 - 01/2002
7Drug Therapy (Chemotherapy)
01/2022 - 11/2006
4Radiotherapy
11/2015 - 11/2005
2Boron Neutron Capture Therapy
01/2022 - 12/2020
1Laminectomy
10/2021
1Pneumonectomy (Lung Volume Reduction)
03/2021
1Hepatectomy
03/2021